WEC
CHTP

Winslow Evans & Crocker’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Winslow Evans & Crocker’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-300
Closed -$1K – 1474
2013
Q4 		$1K Buy
+300
New +$1.01K ﹤0.01% 1382

Other funds holding CHTP

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GH
Green Holdings Hamilton, Bermuda $9.16M AUM 15.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Winslow Evans & Crocker's CHTP Position: Q1 2014 in Review

Winslow Evans & Crocker sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q1 2014, closing a stake of 300 shares — an estimated $1K sold.

Winslow Evans & Crocker first reported a position in CHTP in Q4 2013 and held it in 1 quarter. The position peaked at $1K in Q4 2013. 85 funds tracked by Wall St. Rank hold CHTP as of Q1 2014.

  • Winslow Evans & Crocker reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q1 2014 after selling out during the quarter.
  • Winslow Evans & Crocker sold 300 CHELSEA THERAPEUTICS INT'L LTD shares in Q1 2014, an estimated $1K.
  • Winslow Evans & Crocker first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q4 2013 and held it in 1 quarter.
  • Winslow Evans & Crocker's CHELSEA THERAPEUTICS INT'L LTD position peaked at $1K in Q4 2013.
  • 85 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q1 2014.

Based on Winslow Evans & Crocker's 13F filing for Q1 2014, filed 11 Apr 2014.